Reviva Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -7,847 | -7,422 | |
EBIT | -8,129 | -7,922 | |
Net Income | -7,859 | -7,433 | -9,724 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -8,476 | -11,725 | -8,876 |
Cash | 6,178 | 11,973 | 23,367 |
Basic Shares | 30,555 | 29,887 | 27,918 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -724 | |||
EBITDA | -39,503,636,000 | -24,111 | -8,513 | -2,328 |
EBIT | -24,306 | -10,104 | -2,434 | |
Net Income | -39,260,837,000 | -24,339 | -8,521 | -3,783 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -28,324 | -18,960 | -10,668 | -3,725 |
Cash | 23,367 | 18,519 | 29,687 | 8,760 |
Basic Shares | 23,798 | 19,516 | 14,790 | 3,061 |
